|  | HGSOC | LGSOC | MOC | EOC | CCOC | Others |
---|---|---|---|---|---|---|---|
Number of patients | 245 | 35 | 50 | 97 | 62 | 27 | |
Age at diagnosis (years) | 57 (8.2) | 53.9 (11.8) | 53.4 (12.4) | 54.5 (9.4) | 55.8 (7.4) | 56.2 (9) | |
Entry time (months) | 23.5 (18.9 to 32.1) | 26.4 (19.6 to 33.5) | 28 (18.2 to 47.6) | 28.7 (21.2 to 46.4) | 29.4 (19.4 to 59.6) | 27.8 (23.1 to 31.6) | |
Last follow-up time (months) | 71.1 (45.4 to 105.6) | 126.5 (85.7 to 149.1) | 123 (83.1 to 170.3) | 140.9 (86.5 to 171.2) | 144.8 (101.6 to 208.2) | 97.8 (73.7 to 139.7) | |
Vital status | Data available | 245 (100%) | 35 (100%) | 50 (100%) | 97 (100%) | 62 (100%) | 27 (100%) |
 | Alive | 89 (36%) | 27 (77%) | 39 (78%) | 69 (71%) | 47 (76%) | 16 (59%) |
 | Died | 156 (64%) | 8 (23%) | 11 (22%) | 28 (29%) | 15 (24%) | 11 (41%) |
Stage | Data available | 238 (97%) | 33 (94%) | 47 (94%) | 96 (99%) | 62 (100%) | 24 (89%) |
 | I | 46 (19%) | 27 (82%) | 42 (89%) | 76 (79%) | 50 (81%) | 13 (54%) |
 | II | 27 (11%) | 2 (6%) | 1 (2%) | 13 (14%) | 6 (10%) | 5 (21%) |
 | III | 139 (58%) | 4 (12%) | 4 (9%) | 6 (6%) | 5 (8%) | 5 (21%) |
 | IV | 26 (11%) | 0 (0%) | 0 (0%) | 1 (1%) | 1 (2%) | 1 (4%) |
Grade | Data available | 201 (82%) | 13 (37%) | 26 (52%) | 78 (80%) | 26 (42%) | 11 (41%) |
 | I | 1 (0%) | 11 (85%) | 10 (38%) | 22 (28%) | 2 (8%) | 1 (9%) |
 | II | 56 (28%) | 1 (8%) | 14 (54%) | 40 (51%) | 11 (42%) | 7 (64%) |
 | III | 144 (72%) | 1 (8%) | 2 (8%) | 16 (21%) | 13 (50%) | 3 (27%) |
PTEN status (IF) | Data available | 214 (87%) | 29 (83%) | 41 (82%) | 89 (92%) | 59 (95%) | 26 (96%) |
 | Negative | 49 (23%) | 2 (7%) | 12 (29%) | 39 (44%) | 34 (58%) | 8 (31%) |
 | Weak positive | 68 (32%) | 6 (21%) | 11 (27%) | 27 (30%) | 18 (31%) | 8 (31%) |
 | Heterogeneous | 48 (22%) | 7 (24%) | 2 (5%) | 3 (3%) | 1 (2%) | 3 (12%) |
 | Positive | 49 (23%) | 14 (48%) | 16 (39%) | 20 (22%) | 6 (10%) | 7 (27%) |
PTEN status (IHC) | Data available | 211 (86%) | 28 (80%) | 44 (88%) | 90 (93%) | 56 (90%) | 26 (96%) |
 | Negative | 53 (25%) | 3 (11%) | 9 (20%) | 35 (39%) | 22 (39%) | 4 (15%) |
 | Weak positive | 73 (35%) | 8 (29%) | 5 (11%) | 28 (31%) | 18 (32%) | 5 (19%) |
 | Heterogeneous | 34 (16%) | 3 (11%) | 6 (14%) | 6 (7%) | 3 (5%) | 3 (12%) |
 | Positive | 51 (24%) | 14 (50%) | 24 (55%) | 21 (23%) | 13 (23%) | 14 (54%) |